Assignee
ELEUSIS BENEFIT CORP PBC
US·0 granted patents·4 pending applications·0 citations·filing 2016–2019
Top patents by PatentIndex Score
4 records- 0140US2020085816A1Lsd for the treatment of alzheimer's diseaseELEUSIS BENEFIT CORP PBC·Filed 2019·Application pending·0 cites
- 0230US2018036303A1Lsd for the treatment of alzheimer's diseaseELEUSIS BENEFIT CORP PBC·Filed 2016·Application pending·0 cites
- 0323US2021183519A1Methods and systems for enhancing safety of psychedelic drug therapiesELEUSIS BENEFIT CORP PBC·Filed 2018·Application pending·0 cites
- 0420US2020147038A1Assessing and treating psychedelic-responsive subjectsELEUSIS BENEFIT CORP PBC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ELEUSIS BENEFIT CORP PBC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →